Home
Andrew Hollman Meyer, Chief Business Officer: Janux Therapeutics JANX Sell · Filed 25/05/02
Trade details
- Type
- Insider sale
- Amount
- $93,709.35
- Shares · price
- 2,933 sh · $31.95 a share
- Held after
- 82,539 sh
- Trade date
- 25/05/01
- Filed
- 25/05/02
- Days to filing
- 1 days
Sold 3.4% of holdings
- Share of holding sold
- 3.4%
Janux Therapeutics trades, last 26 weeks
What else happened in Janux Therapeutics around then
Filed or reported within 30 days of the trade day · 25/04/01~25/05/31Andrew Hollman Meyer's recent trades
- Andrew Hollman Meyer
Planned saleJanux Therapeutics
Planned saleJanux Therapeutics
JANX
$28.2K
1,877 sh
$28.2K
Filed 04/13
Traded 04/13
- Andrew Hollman Meyer
Planned saleJanux Therapeutics
Planned saleJanux Therapeutics
JANX
$2.6M
178,767 sh
$2.6M
Filed 01/26
Traded 01/26
- Andrew Hollman Meyer
Planned saleJanux Therapeutics
Planned saleJanux Therapeutics
JANX
$1.7M
118,122 sh
$1.7M
Filed 01/23
Traded 01/23
- Andrew Hollman Meyer
SellJanux Therapeutics
SellJanux Therapeutics
JANX
$25.8K
1,879 sh
$25.8K
Filed 01/02
Traded 01/02
- Andrew Hollman Meyer
Sell10b5-1 planJanux Therapeutics
Sell10b5-1 planJanux Therapeutics
JANX
$88.7K
2,700 sh
$88.7K
Filed 25/12/03
Traded 25/12/01